Lifeist Wellness Inc. (LFST.V)
CAD 0.04
(0.0%)
CAD 0.04
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 5.34 Million CAD | -167.11% |
| 2022 | 3.79 Million CAD | 125.63% |
| 2021 | 1.68 Million CAD | 15.3% |
| 2020 | 1.45 Million CAD | 7.48% |
| 2019 | 1.35 Million CAD | -73.79% |
| 2018 | 5.17 Million CAD | 275.69% |
| 2017 | 1.37 Million CAD | 23.0% |
| 2016 | 1.12 Million CAD | -44.06% |
| 2015 | 2 Million CAD | 5601.3% |
| 2014 | -36.41 Thousand CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.5 Million CAD | 379.53% |
| 2024 Q3 | -304.34 Thousand CAD | -65.99% |
| 2024 Q2 | 1.9 Million CAD | 26.67% |
| 2023 Q3 | 1.39 Million CAD | 316.08% |
| 2023 Q2 | -645.31 Thousand CAD | -146.12% |
| 2023 Q1 | 1.39 Million CAD | 211.73% |
| 2023 FY | -2.54 Million CAD | -167.11% |
| 2023 Q4 | -536.6 Thousand CAD | -138.48% |
| 2022 Q4 | 448.85 Thousand CAD | -85.16% |
| 2022 Q2 | -485.06 Thousand CAD | -136.07% |
| 2022 Q1 | 1.34 Million CAD | 95.97% |
| 2022 FY | 3.79 Million CAD | 125.63% |
| 2022 Q3 | 3.02 Million CAD | 723.52% |
| 2021 Q4 | 686.21 Thousand CAD | -21.4% |
| 2021 Q2 | 292.78 Thousand CAD | 271.91% |
| 2021 Q1 | -170.31 Thousand CAD | -123.24% |
| 2021 FY | 1.68 Million CAD | 15.3% |
| 2021 Q3 | 873.09 Thousand CAD | 198.21% |
| 2020 Q2 | 543.53 Thousand CAD | -5.36% |
| 2020 Q1 | 574.33 Thousand CAD | 138.91% |
| 2020 Q3 | 416.97 Thousand CAD | -23.28% |
| 2020 Q4 | -76.29 Thousand CAD | -118.3% |
| 2020 FY | 1.45 Million CAD | 7.48% |
| 2019 Q3 | 992.94 Thousand CAD | 16.39% |
| 2019 Q1 | 987.12 Thousand CAD | 8.14% |
| 2019 Q2 | 853.1 Thousand CAD | -13.58% |
| 2019 Q4 | -1.47 Million CAD | -248.66% |
| 2019 FY | 1.35 Million CAD | -73.79% |
| 2018 Q1 | 1.97 Million CAD | 25.23% |
| 2018 FY | 5.17 Million CAD | 275.69% |
| 2018 Q4 | 912.84 Thousand CAD | -1.94% |
| 2018 Q3 | 930.88 Thousand CAD | 6.62% |
| 2018 Q2 | 873.1 Thousand CAD | -55.86% |
| 2017 Q2 | 532.03 Thousand CAD | -35.64% |
| 2017 Q1 | 826.6 Thousand CAD | 21.02% |
| 2017 FY | 1.37 Million CAD | 23.0% |
| 2017 Q4 | 1.57 Million CAD | 624.67% |
| 2017 Q3 | -301.05 Thousand CAD | -156.59% |
| 2016 Q4 | 683.01 Thousand CAD | 995.98% |
| 2016 Q2 | 353.36 Thousand CAD | 11.66% |
| 2016 FY | 1.12 Million CAD | -44.06% |
| 2016 Q1 | 316.46 Thousand CAD | -18.51% |
| 2016 Q3 | 62.32 Thousand CAD | -82.36% |
| 2015 FY | 2 Million CAD | 5601.3% |
| 2015 Q4 | 388.33 Thousand CAD | -23.58% |
| 2015 Q3 | 508.13 Thousand CAD | 10.51% |
| 2015 Q2 | 459.82 Thousand CAD | -62.43% |
| 2015 Q1 | 1.22 Million CAD | 2771.75% |
| 2014 Q4 | -45.81 Thousand CAD | 0.0% |
| 2014 FY | -36.41 Thousand CAD | 0.0% |
| 2014 Q3 | -45.81 Thousand CAD | -169.89% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 Q2 | 65.54 Thousand CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2009 Q1 | - CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| 2008 Q4 | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 5499.00 CAD | -97086.488% |
| CanadaBis Capital Inc. | 11.78 Million CAD | 54.647% |
| Decibel Cannabis Company Inc. | 41.85 Million CAD | 87.233% |
| Delivra Health Brands Inc. | 6.39 Million CAD | 16.482% |
| Entourage Health Corp. | 3.7 Million CAD | -44.14% |
| Cannara Biotech Inc. | 27.23 Million CAD | 80.374% |
| Medicure Inc. | 13.98 Million CAD | 61.797% |
| PharmaCielo Ltd. | -1.36 Million CAD | 490.425% |
| Rubicon Organics Inc. | 13.14 Million CAD | 59.331% |
| BioSyent Inc. | 25.14 Million CAD | 78.744% |
| Voyageur Pharmaceuticals Ltd. | -2185.00 CAD | 244689.703% |